Invus

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

Develops a brain-computer interface intended to help people with paralysis operate digital devices.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

Develops fungal genome-derived therapeutics for organ transplant rejection

City Therapeutics develops RNA-interference therapeutics and an engineering platform across disease areas.

Develops hormonal and non-hormonal male contraceptives for men and couples globally

Develops and manufactures adaptive robots for complex tasks

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

Develops medicines targeting historically undruggable protein targets in cancer

ezCater connects workplaces with restaurants and helps organisations manage catering, meal programs and food spending.